WORLD HEALTH

Global Diseases News

For readers following diseases, this page covers diagnosis, treatment breakthroughs and public health impact. Reporting follows clinical trials, regulatory decisions and disease awareness campaigns.

Wolbachia Mosquitoes Cut Dengue Infections 69%

Wolbachia Mosquitoes Cut Dengue Infections 69%

In a four-year Brazilian study, neighborhoods that received the bacteria-carrying mosquitoes saw far fewer dengue and chikungunya cases among schoolchildren.

Live Poll

Would you support releasing specially bred mosquitoes in your community to reduce dengue?


Asthma

Asthma

Malaysia Pushes Stronger ASEAN Action on Haze

Residents across Southeast Asia face unhealthy air as Malaysia proposes a Sustainable Haze Fund and coordinated regional response.

Malaysia Pushes Stronger ASEAN Action on Haze

Cancer

Cancer

Experimental AML Vaccine Extends Survival in Trial

Adults with high-risk acute myeloid leukemia saw median survival of 24 months on galinpepimut-S versus under 15 months on standard options in a phase 3 trial.

Experimental AML Vaccine Extends Survival in Trial

Stroke

Stroke

Asundexian Cuts Stroke Risk Without Added Bleeding

Adults with a recent ischemic stroke or high-risk TIA saw fewer repeat strokes on the drug, with no clear rise in major bleeding.

Asundexian Cuts Stroke Risk Without Added Bleeding

Diseases — General

Diseases — General

Kidney Estimate Gaps Linked to Higher Death Risk

In a study of over 800,000 outpatients, large gaps between two kidney blood tests were tied to higher rates of death and heart failure.


Diabetes

Live Poll

Would you break up your sitting with short walks during the day?

Diabetes

Short Walks May Beat One Long Walk for Blood Sugar

In a small pilot, sedentary adults with overweight or obesity who walked in 10 short bouts a day had better blood sugar control.

Short Walks May Beat One Long Walk for Blood Sugar

More in Diseases

Day to day, that means research breakthroughs, trial results, disease outbreaks and updates to prevention guidelines. It reaches every region and institution where medical research is conducted or treatment is provided. International health mandates and surveillance networks often dictate the pace of reporting when a specific condition emerges as a public health priority. New treatment approvals and the study of risk factors are the subjects that recur most consistently across the landscape.